Gene therapy for primary immune deficiencies: a Canadian perspective

The use of gene therapy (GT) for the treatment of primary immune deficiencies (PID) including severe combined immune deficiency (SCID) has progressed significantly in the recent years. In particular, long-term...

from A1 via xlomafota.13 on Inoreader http://ift.tt/2ltarvt
via IFTTT

http://ift.tt/2lOfrxu